BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26649804)

  • 1. TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.
    Bhansali M; Zhou J; Shemshedini L
    Mol Endocrinol; 2016 Jan; 30(1):13-25. PubMed ID: 26649804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes.
    Khatiwada P; Rimal U; Han Z; Malla M; Zhou J; Shemshedini L
    Endocrinology; 2023 Mar; 164(5):. PubMed ID: 36951301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
    Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
    Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
    Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARF represses androgen receptor transactivation in prostate cancer.
    Lu W; Xie Y; Ma Y; Matusik RJ; Chen Z
    Mol Endocrinol; 2013 Apr; 27(4):635-48. PubMed ID: 23449888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation.
    Daniels G; Zhang X; Zhong X; Santiago L; Wang LH; Wu X; Zhang JY; Liang F; Li X; Neubert TA; Steinke L; Shen Y; Basch R; Schneider R; Levy DE; Lee P
    Oncotarget; 2016 Jun; 7(26):39556-39571. PubMed ID: 27127173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
    Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
    Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
    Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
    Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer.
    Khatiwada P; Rimal U; Han Z; Shemshedini L
    Endocr Oncol; 2024 Jan; 4(1):e230017. PubMed ID: 38410785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.